The EU pharmaceutical package aims to accelerate life sciences industries growth and promote sustainable healthcare systems for European patients. Patient access, market access, availability disparities, supply shortages, and supply chain and innovation challenges drive review and reform of the EU pharmaceutical legislation—the foundation of pharmaceutical industry manufacturing of safe, effective, high quality medicinal products in Malta and European countries.
